BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33160946)

  • 1. Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: The LANDMARK trial.
    Kawashima H; Soliman O; Wang R; Ono M; Hara H; Gao C; Zeller E; Thakkar A; Tamburino C; Bedogni F; Neumann FJ; Thiele H; Abdel-Wahab M; Morice MC; Webster M; Rosseel L; Mylotte D; Onuma Y; Wijns W; Baumbach A; Serruys PW
    Am Heart J; 2021 Feb; 232():23-38. PubMed ID: 33160946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
    Baumbach A; van Royen N; Amat-Santos IJ; Hudec M; Bunc M; Ijsselmuiden A; Laanmets P; Unic D; Merkely B; Hermanides RS; Ninios V; Protasiewicz M; Rensing BJWM; Martin PL; Feres F; De Sousa Almeida M; van Belle E; Linke A; Ielasi A; Montorfano M; Webster M; Toutouzas K; Teiger E; Bedogni F; Voskuil M; Pan M; Angerås O; Kim WK; Rothe J; Kristić I; Peral V; Garg S; Elzomor H; Tobe A; Morice MC; Onuma Y; Soliman O; Serruys PW;
    Lancet; 2024 May; ():. PubMed ID: 38795719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of the novel Myval Octacor transcatheter heart valve in severe, symptomatic aortic valve stenosis - A real-world Indian experience (The OCTACOR India Study).
    Jose J; Mandalay A; Cholenahally MN; Khandenahally RS; Budnur SC; Parekh M; Rao RS; Seth A; Chandra P; Kapoor R; Agarwal P; Mathur A; Kumar V; Kanchanahalli SS; Mullasari AS; Subban V; Khanolkar UB; Mehrotra S; Chopra M; Jain RK; Mehta H; Gupta R; Kumar V; Raghuraman B; Shastri N; Elzomor H; Soliman O; Gunasekaran S
    Cardiovasc Revasc Med; 2024 Jun; 63():1-7. PubMed ID: 38423848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of TAVI valves: The Compare-TAVI trial.
    Terkelsen CJ; Thim T; Freeman P; Dahl JS; Nørgaard BL; Kim WY; Tang M; Sørensen HT; Christiansen EH; Nissen H
    Am Heart J; 2024 Aug; 274():84-94. PubMed ID: 38729550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfemoral transcatheter aortic valve replacement with VitaFlow
    Zhang J; Kong XQ; Gao XF; Chen J; Chen X; Li B; Shao YB; Wang Y; Jiang H; Zhu JC; Zhang JJ; Chen SL;
    Am Heart J; 2024 May; 271():76-83. PubMed ID: 38412895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis Comparing Early Outcomes Following Transcatheter Aortic Valve Implantation With the Evolut Versus Sapien 3 Valves.
    Alperi A; Faroux L; Muntané-Carol G; Rodés-Cabau J
    Am J Cardiol; 2021 Jan; 139():87-96. PubMed ID: 33190806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the 32 mm Myval transcatheter heart valve for treatment of aortic stenosis in patients with extremely large aortic annuli in real-world scenario: First global, multicenter experience.
    Holzamer A; Bedogni F; van Wyk P; Barwad P; Protasiewicz M; Ielasi A; Nombela-Franco L; Seidler T; Hilker M
    Catheter Cardiovasc Interv; 2023 Dec; 102(7):1364-1375. PubMed ID: 37698335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study.
    Vahl TP; Thourani VH; Makkar RR; Hamid N; Khalique OK; Daniels D; McCabe JM; Satler L; Russo M; Cheng W; George I; Aldea G; Sheridan B; Kereiakes D; Golwala H; Zahr F; Chetcuti S; Yadav P; Kodali SK; Treede H; Baldus S; Amoroso N; Ranard LS; Pinto DS; Leon MB
    Lancet; 2024 Apr; 403(10435):1451-1459. PubMed ID: 38552656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single center experience with the balloon-expandable Myval transcatheter aortic valve system with the first 100 patients: 30-day and 1-year follow-up.
    Magyari B; Kittka B; Goják I; Kasza G; Schönfeld K; Szapáry LB; Simon M; Kiss R; Bertalan A; Várady E; Gyimesi A; Szokodi I; Horváth I
    Catheter Cardiovasc Interv; 2023 Dec; 102(7):1317-1330. PubMed ID: 37870123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of balloon-expandable valves according to the implantation strategy: insight from the DIRECTAVI trial.
    Jammoul N; Dupasquier V; Akodad M; Meunier PA; Moulis L; Soltani S; Macia JC; Robert P; Schmutz L; Steinecker M; Piot C; Targosz F; Benkemoun H; Lattuca B; Roubille F; Cayla G; Leclercq F
    Am Heart J; 2024 Apr; 270():13-22. PubMed ID: 38253304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. German Experience with a Novel Balloon-Expandable Heart Valve Prosthesis for Transcatheter Aortic Valve Implantation-Outcomes of the MYLAND (MYvaL germAN stuDy) Study.
    Ubben T; Tigges E; Kim WK; Holzamer A; Breitenbach I; Sodian R; Rothe J; Hochholzer W; Hakmi S; Neumann FJ
    J Clin Med; 2024 May; 13(11):. PubMed ID: 38892875
    [No Abstract]   [Full Text] [Related]  

  • 12. Transcatheter Aortic Valve Replacement With the Navitor System: Real-World United Kingdom Experience.
    Bharucha AH; Kanyal R; Mullen M; Patel K; Smith D; Shome J; Blackman DJ; Aktaa S; Williams PD; Khogali S; Dworakowski R; Eskandari M; Byrne J; MacCarthy P
    Am J Cardiol; 2024 Jul; 222():23-28. PubMed ID: 38692400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of contemporary transcatheter heart valve prostheses: data from the German Aortic Valve Registry (GARY).
    Rudolph TK; Herrmann E; Bon D; Walther T; Bauer T; Ensminger S; Frerker C; Beckmann A; Möllmann H; Bekeredjian R; Beyersdorf F; Hamm C; Baldus S; Böning A; Gummert J; Rudolph V; Bleiziffer S
    Clin Res Cardiol; 2024 Jan; 113(1):75-85. PubMed ID: 37462856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and rationale of the evaluation of transcatheter aortic valve replacement compared to surveillance for patients with asymptomatic severe aortic stenosis: The EARLY TAVR trial.
    Généreux P; Schwartz A; Oldemeyer B; Cohen DJ; Redfors B; Prince H; Zhao Y; Lindman BR; Pibarot P; Leon MB
    Am Heart J; 2024 Feb; 268():94-103. PubMed ID: 38056546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Center Experience with the Balloon-Expandable Myval Transcatheter Aortic Valve System in Patients with Bicuspid Anatomy: Procedural and 30-Day Follow-Up.
    Magyari B; Kittka B; Goják I; Schönfeld K; Szapáry LB; Simon M; Kiss R; Bertalan A; Várady E; Gyimesi A; Szokodi I; Horváth IG
    J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256647
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical outcomes of the Myval transcatheter heart valve system in patients with severe aortic valve stenosis: a two-year follow-up observational study.
    Kilic T; Ielasi A; Ninios V; Korkmaz L; Panagiotakos D; Yerlikaya G; Ozderya A; Montonati C; Tespili M; Coskun S; Sahin T; Ninios I; Vlasopoulou K; Konus AH; Kul S; Akyuz AR
    Arch Med Sci; 2024; 20(2):410-419. PubMed ID: 38757027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deformation in transcatheter heart valves: Clinical implications and considerations.
    Fukui M; Cavalcante JL; Bapat VN
    J Cardiol; 2024 Jun; 83(6):351-358. PubMed ID: 38432474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Aortic Dissection After Transcatheter Aortic Valve Replacement.
    Ashwat E; Ahmad D; Sá MP; Jackson A; Brown JA; Serna-Gallegos D; West D; Sultan I
    Am J Cardiol; 2024 Jul; 222():108-112. PubMed ID: 38750948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of multiple resheathing during transcatheter aortic valve implantation with Evolut self-expanding valves.
    Aurigemma C; Busco M; Bianchini F; Bianchini E; Di Brango C; Marchetta M; Bruno P; Nesta M; Romagnoli E; Burzotta F; Trani C
    Int J Cardiol; 2024 May; 410():132218. PubMed ID: 38815673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter heart valve explant with infective endocarditis-associated prosthesis failure and outcomes: the EXPLANT-TAVR international registry.
    Marin-Cuartas M; Tang GHL; Kiefer P; Fukuhara S; Lange R; Harrington KB; Saha S; Hagl C; Kleiman NS; Goel SS; Kempfert J; Werner P; Petrossian GA; Geirsson A; Desai ND; Chu MWA; Bhadra OD; Shults C; Garatti A; Vincent F; Grubb KJ; Goldberg JB; Mack MJ; Modine T; Denti P; Kaneko T; Bapat VN; Reardon MJ; Borger MA; Zaid S;
    Eur Heart J; 2024 May; ():. PubMed ID: 38820201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.